Life-prolonging cancer drugs could be funded sooner
New Zealand badly lags behind other developed countries for funded myeloma drugs.
AdvertisementAdvertise with NZME.
Latest from Pharmaceuticals
Desperate Pharmac plea from family selling cans for unfunded cancer drugs
A desperate Auckland family is collecting cans to try fund blood cancer medication.
Can weight-loss pills and dieting cause eating disorders?
The demand for off-label weight-loss drugs like Ozempic is starting to get concerning.
Prescription blunder leaves Alexandra woman ‘angry and scared’
Medical botch-up led to woman having to delay having children.
The link between birth control pills and sex drive
New York Times: The pill lowers testosterone. What does that do to libido?
Twelve treatments for thinning hair that actually work
Telegraph: There's no miracle solution, but these are the treatments that can help.
'Financial pressure': Chemist Warehouse store sparks concern among pharmacists
Return of $5 fee could affect how community pharmacies compete, says spokesman.
Is dieting pointless? Here’s what the data says
New York Times: Experts explain what dieting can — and can’t — do for you.
What should I do with old medications?
Here's what to do with expired or unused medicines sitting in your cupboard.
Oprah says she's on a weight-loss drug and ‘done with the shaming’
New York Times: 'I have a predisposition that no amount of willpower is going to control.'
Chemist Warehouse eyed up in huge merger bid
Brash newcomer would merge to create huge new pharmacy company.
Iwi leader fears lifting pseudoephedrine ban will put more P on the streets
'You’re not doing your country any good to put it on the shelves.'
Jarrod Gilbert: The good drugs are returning to chemists
OPINION: The damage caused by stopping pseudoephedrine has been done.
'Fantastic news': Mum cancer-free after international medical trial
Hamilton woman Lisa Martin was among those whose aggressive cancer was eliminated.
Focus Live: Coalition Govt agrees to allow the sale of Pseudoephedrine
Act leader David Seymour at the signing of the coalition agreement with National and NZ First says pseudoephedrine will be back on shelves in time for next winter. Video / Mark Mitchell
Ebos Group's pet project is off, shares fall sharply as trading resumes
Ebos had been in a trading halt since last week.
Menopause checklist: Questions to ask your doctor about HRT
Telegraph: Considering hormone replacement therapy? Here's what you need to know.
'Pretty alarmed': Thousands of Kiwis with ADHD forced to switch drugs after supply problems
Global demand has been blamed for the shortage of Teva, a common ADHD drug.
Can some antidepressants cause lasting sexual problems?
NY Times: Some patients say symptoms persist long after they've stopped taking SSRIs.
Obesity drug cuts risk of death by 18 per cent
Wegovy has been found to have a 'quite profound' effect on reducing heart attack risk.
Pseudoephedrine question reflects failure of meth policy - expert
"We have taken the eye off methamphetamine."
‘Meno-washing’: Are midlife women being scammed?
Telegraph: Menopause has come out of the shadows. So have the snake oil merchants.
Some psychiatrists have started prescribing Ozempic. Others are worried
New York Times: 'These medications were not studied well or designed for this population.'
Medicinal cannabis producers gear up to sell products prescription-free
Rule change a 'surprise' but health regulator claims potential safety issues exist.
What is behind the unexpected decline in dementia?
Financial Times: Global data on new cases of dementia offers an unexpected ray of hope.
Pharmac CEO's fate revealed over Rachel Smalley email saga
Pharmac's board met today amid a deepening crisis over internal emails.
Pharmac email crisis: Emailer apologises to Smalley; Chair meets bosses; Calls for CEO sacking
The PM steps into the Pharmac email row, labelling comments 'totally unacceptable'.
Western companies take slow steps towards China ‘de-risking’
Financial Times: Strategies focus on ways to insulate China operations, not reduce them.
Young mum's $100k bill for cancer drugs that has political parties at odds
Adrienne Smithson says her 'world was tipped upside down' after her diagnosis at age 44.
Opinion: The economic promise of anti-obesity drugs
Financial Times: Over 1 billion people worldwide are obese, according to the WHO.
How Ozempic and Wegovy are reshaping Denmark's economy
New York Times: Novo Nordisk’s market value has exceeded the size of the Danish economy.
Superbugs: Why it’s so hard to stop the ‘silent pandemic’
Financial Times: Antimicrobial resistance already kills millions - and it's getting worse.
'We are in a crisis': Patients call for access to new meds
MyLifeMatters collective represents over a million patients with life-limiting conditions.
Opinion | Pharmac in the dark shadow of adversarial politics
OPINION: Drug-buying agency has received huge criticism. For what?